Stryker announced that it has completed the previously announced acquisition of SERF SAS, a France-based joint replacement company, from Menix.
“The acquisition of SERF SAS further strengthens our global portfolio and reinforces our dedication to orthopaedic excellence,” said Katherine Truppi, president of Stryker’s Joint Replacement division. “We welcome the SERF SAS team to Stryker and look forward to working together to help advance product innovation and customer satisfaction.”
SERF SAS is recognized for its innovations in hip implants, including the invention of the original Dual Mobility Cup, according to Stryker. This acquisition complements Stryker’s existing presence in France and across Europe as well as its global joint replacement portfolio, allowing Stryker to serve a wider range of patients by strengthening its implant product line.
“The SERF SAS product portfolio is built on a trusted legacy within the orthopaedic industry,” said Mathieu Badard, vice president and general manager, Stryker’s Joint Replacement division, Europe. “We are thrilled to combine our best-in-class product portfolios and work together to expand our presence within Europe and increase patient access to differentiated products for joint replacement.”